Scientific Advisory Committee on Health Products for Women (SAC-HPW): Agenda

Date and Time: June 23, 2021- 11:00 am-4:15 pm, EST
Location: Virtual
Chairperson: Lorraine Greaves (Chair), Louise Pilote (Vice-chair)
Secretariat: Jenna Griffiths, Laetitia Guillemette, Roslyn Neals, Therapeutic Products Directorate (TPD)
Participants: SAC-HPW members and Health Canada employees

11:00-11:15
In-camera Session
SAC-HPW members only

11:15-11:20
Welcome and Opening Remarks
Chief Medical Advisor, Health Canada and Senior Medical Advisor for Health Products and Food Branch

11:20-11:30
Chair’s Address, Introduction of Members, Review of Affiliations and Interests (A&I), Review of Agenda
Chair

11:30-11:35
Introduction to the Facilitator’s Role, Meeting Logistics
Facilitator

11:35-11:50
Actions in Response to SAC-HPW Recommendations
Director General, Medical Devices Directorate

11:50-12:30
Session #1a: Drug Authorisation Process
Therapeutic Products Directorate (TPD)

12:30-1:00
Lunch Break

1:00-2:00
Session #1b: Considerations for SGBA+ During Drug Submission Review & Labelling
Biologics and Radiopharmaceutical Drugs Directorate

2:00-2:15
Break

2:15-2:45
Session #2: SGBA+ Strategy for HPFB (in development)
BRDD

2:45-3:45
Session #2: Committee Deliberations/Recommendations
SAC-HPW members

3:45-3:50
Overview of Next Meeting
SAC-HPW Secretariat

3:50-4:00
Summary of Recommendations and Adjournment of Meeting
Chair

4:00-4:15
In-camera Session
SAC-HPW members only